Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.
Ontology highlight
SUBMITTER: Alves CL
PROVIDER: S-EPMC8446011 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA